CANCER TARGETED GENE PANEL - LUNG
This panel aids in prognostication and therapeutic decisions for Lung carcinoma where mutation has been demonstrated in MET, BRAF, EGFR, ERBB2 and KRAS and copy number variations in ALK1, ROS1 and MET. It also enables the screening of clinically actionable targets for personalized targeted medicine in Lung adenocarcinoma.
Parameter(s) covered : 8
Report Frequency: Sample Tue by 9 am; Report 10 Working days
Special Instruction: Tissue block must contain at least 10% tumor tissue. Physician prescription is mandatory.
Price : ₹ 21600.00
Parameters
- EGFR Exon 18 Mutation
- EGFR Exon 19 Mutation
- EGFR Exon 20 Mutation
- EGFR Exon 21 Mutation
- MET (7q31) Gene Amplification
- NGS LUNG PANEL
- RESULT ATTACHED
- SEND OUT COMMENT